Search Results 1121-1130 of 17673 for Extracellular
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...
MVI is a type of injury to small blood vessels in the transplanted kidney and may be a sign of rejection by the body. It can lead to serious kidney problems ...
Mayo Clinic's Cell and Molecular Aging Lab, led by Joao Passos, Ph.D., studies cellular senescence to find new interventions for age-associated chronic ...
The purpose of this study of sulfasalazine is to see how well it works in preventing acute diarrhea in patients with cancer who are undergoing pelvic radiation ...
The purpose of this study is to determine the prevalence of genetic mutations in cancer patients from various ethnic populations seeking care at Mayo Clinic ...
The purpose of this study is to evaluate the endoscopic removability of the Evolution® esophageal fully covered stent when used to treat patients with an ...
The purpose of this study is to develop two quantitative risk scores for MAC-PD that computationally integrates clinical, immunological, and pharmacological ...
The Parkinson Progression Marker Initiative (PPMI) is a study to assess progression of clinical features, digital outcomes, and imaging, biologic and ...
Genetically manipulating protein level in colon cancer cells can improve effectiveness of chemotherapy, Mayo Clinic study finds. Jay Furst. August 26, 2019.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.